blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0419513

EP0419513 - RECOMBINANT FLAGELLIN VACCINES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  02.03.1996
Database last updated on 15.06.2024
Most recent event   Tooltip02.03.1996No opposition filed within time limitpublished on 17.04.1996 [1996/16]
Applicant(s)For all designated states
AMERICAN CYANAMID COMPANY
One Portland Square
Portland, Maine 04101 / US
For all designated states
THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Stanford, California 94305 / US
[N/P]
Former [1995/45]For all designated states
AMERICAN CYANAMID COMPANY
One Portland Square
Portland, Maine 04101 / US
For all designated states
THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Stanford, California 94305 / US
Former [1991/14]For all designated states
PRAXIS BIOLOGICS, INC.
30 Corporate Woods
Rochester New York 14623 / US
For all designated states
THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Stanford, California 94305 / US
Inventor(s)01 / MARJARIAN, William, Robert
17 Green Hill Lane
Pittsford, NY 14534 / US
02 / STOCKER, Bruce, Arnold, Dunbar
410 La Mesa Drive
Menlo Park, CA 94025 / US
03 / NEWTON, Salete, Maria, Cardozo
2680 Fayette Drive 211
Mountain View, CA 94040 / US
[1991/14]
Representative(s)Allam, Peter Clerk, et al
Lloyd Wise Commonwealth House, 1-19 New Oxford Street
London WC1A 1LW / GB
[N/P]
Former [1991/14]Allam, Peter Clerk, et al
LLOYD WISE, TREGEAR & CO. Norman House 105-109 Strand
London WC2R 0AE / GB
Application number, filing date89906507.205.05.1989
[1991/14]
WO1989US01932
Priority number, dateUS1988019057005.05.1988         Original published format: US 190570
[1991/14]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO8910967
Date:16.11.1989
Language:EN
[1989/27]
Type: A1 Application with search report 
No.:EP0419513
Date:03.04.1991
Language:EN
The application published by WIPO in one of the EPO official languages on 16.11.1989 takes the place of the publication of the European patent application.
[1991/14]
Type: B1 Patent specification 
No.:EP0419513
Date:26.04.1995
Language:EN
[1995/17]
Search report(s)International search report - published on:EP16.11.1989
ClassificationIPC:C12N15/31, C12N15/62, A61K39/295, A61K39/116, A61K39/015, A61K39/00
[1995/17]
CPC:
C07K14/005 (EP); A61P31/04 (EP); C07K14/24 (EP);
C07K14/445 (EP); A61K38/00 (EP); A61K39/00 (EP);
C07K2319/00 (EP); C07K2319/40 (EP); C07K2319/55 (EP);
C07K2319/735 (EP); C12N2730/10122 (EP); Y02A50/30 (EP) (-)
Former IPC [1991/14]C12N15/00, A61K39/295, A61K39/116, A61K39/015, A61K39/00
Designated contracting statesAT,   BE,   CH,   DE,   FR,   GB,   IT,   LI,   NL,   SE [1991/14]
TitleGerman:REKOMBINANTE VAKZINE VON FLAGELLIN[1991/14]
English:RECOMBINANT FLAGELLIN VACCINES[1991/14]
French:VACCINS DE FLAGELLINE RECOMBINANTS[1991/14]
Biological materialThis application mentions deposited biological material, check the file for details
Entry into regional phase05.11.1990National basic fee paid 
05.11.1990Designation fee(s) paid 
05.11.1990Examination fee paid 
Examination procedure29.11.1989Request for preliminary examination filed
International Preliminary Examining Authority: DE
05.11.1990Examination requested  [1991/14]
19.05.1992Despatch of a communication from the examining division (Time limit: M06)
24.11.1992Reply to a communication from the examining division
04.03.1993Despatch of a communication from the examining division (Time limit: M06)
14.09.1993Reply to a communication from the examining division
28.10.1993Despatch of a communication from the examining division (Time limit: M04)
24.02.1994Reply to a communication from the examining division
29.06.1994Despatch of communication of intention to grant (Approval: Yes)
25.10.1994Communication of intention to grant the patent
17.01.1995Fee for grant paid
17.01.1995Fee for publishing/printing paid
Opposition(s)27.01.1996No opposition filed within time limit [1996/16]
Fees paidRenewal fee
30.08.1991Renewal fee patent year 03
23.04.1992Renewal fee patent year 04
18.03.1993Renewal fee patent year 05
02.05.1994Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
31.05.199103   M06   Fee paid on   30.08.1991
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational searchEP0184086  [ ] (UNIV LELAND STANFORD JUNIOR [US]);
 WO8702385  [ ] (GENETICS INST [US]);
 EP0237045  [ ] (SHIONOGI & CO [JP]);
 WO8706590  [ ] (BIOENTERPRISES PTY LTD [AU])
    [ ] - Journal of Bacteriology, Volume 168, No. 3, December 1986, American Society for Microbiology, G. KUWAJIMA et al.: "Nucleotide Sequence of the Hag Gene Encoding Flagellin of Escherichia Coli", pages 1479-1483
    [ ] - Infection and Immunity, Volume 55, No. 6, June 1987, American Society for Microbiology, (Washington, DC, US), M.E. JOLIVET et al.: "Induction of Biologically Active Antibodies by a Polyvalent Synthetic Vaccine Constructed without Carrier", pages 1498-1502
    [ ] - Science, volume 231, 28 March 1986, R.C. KENNEDY et al.: "Antiserum to a Synthetic Peptide Recognizes the HTLV-III Envelope Glycoprotein", pages 1556-1559
    [ ] - Proc. Natl. Acad. Sci. USA, Volume 80, December 1983, C.O. JACOB et al.: "Antibodies against Synthetic Peptides of the B Subunit of Cholera Toxin: Crossreaction and Neutralization of the Toxin", pages 7611-7615
    [ ] - Science, Volume 244, April 1989, S.M.C. NEWTON et al.: "Immune Response to Cholera Toxin Epitope Inserted in Salmonella Flagellin", pages 70-72
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.